Stay updated on BMN 111 in Achondroplasia Children Clinical Trial
Sign up to get notified when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.

Latest updates to the BMN 111 in Achondroplasia Children Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check47 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a Phase 3 study for BMN 111 as a treatment for Achondroplasia, including eligibility criteria and study design. The only notable addition is the revision number, which indicates a version update.SummaryDifference25%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to BMN 111 in Achondroplasia Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.